leflunomide has been researched along with Aortitis in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Aortitis: Inflammation of the wall of the AORTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Results of in-vitro studies on Janus kinase (JAK)/signal transducers and activators of transcription and mammalian target of rapamycin (mTOR) pathways, comparative studies with leflunomide as an induction therapy, and a long-term follow-up study with tocilizumab may contribute to the management of Takayasu arteritis." | 5.12 | Aortitis: an update. ( Erdogan, M, 2021) |
| "Noninfectious aortitis has been increasingly reported worldwide with a growing prevalence in western medicine." | 1.56 | Noninfectious aortitis: A case report. ( Hingorani, A; Jaikaran, O; Nicoara, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaikaran, O | 1 |
| Nicoara, M | 1 |
| Hingorani, A | 1 |
| Erdogan, M | 1 |
1 review available for leflunomide and Aortitis
| Article | Year |
|---|---|
Aortitis: an update.
Topics: Antibodies, Monoclonal, Humanized; Aorta; Aortitis; Female; Follow-Up Studies; Giant Cell Arteritis; | 2021 |
1 other study available for leflunomide and Aortitis
| Article | Year |
|---|---|
Noninfectious aortitis: A case report.
Topics: Abdominal Pain; Aged; Aortitis; Back Pain; Glucocorticoids; Humans; Immunosuppressive Agents; Leflun | 2020 |